September 29, 2025

FDA Approves Guselkumab (Tremfya) for Pediatric Plaque Psoriasis, Psoriatic Arthritis – HCPLive

September 29, 2025

FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis | AJMC – The American Journal of Managed Care® (AJMC®)

September 29, 2025

FDA Approves Guselkumab for Pediatric Plaque Psoriasis and Psoriatic Arthritis – Dermatology Times

September 29, 2025

FDA approves Tremfya for pediatric psoriasis and psoriatic arthritis – Investing.com

September 16, 2025

Tips for Managing Psoriasis in Cold Weather – Healthline